CALIFORNIA RESOURCES CORP (CRC)

US13057Q3056 - Common Stock

51.12  +0.74 (+1.47%)

After market: 51.12 0 (0%)

Fundamental Rating

5

Overall CRC gets a fundamental rating of 5 out of 10. We evaluated CRC against 210 industry peers in the Oil, Gas & Consumable Fuels industry. CRC has an average financial health and profitability rating. CRC has a valuation in line with the averages, but on the other hand it scores bad on growth.



6

1. Profitability

1.1 Basic Checks

CRC had positive earnings in the past year.
CRC had a positive operating cash flow in the past year.
CRC had positive earnings in 4 of the past 5 years.
In the past 5 years CRC always reported a positive cash flow from operatings.

1.2 Ratios

CRC's Return On Assets of 6.47% is in line compared to the rest of the industry. CRC outperforms 54.29% of its industry peers.
CRC has a Return On Equity (12.09%) which is in line with its industry peers.
The Return On Invested Capital of CRC (8.55%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CRC is significantly below the industry average of 30.77%.
The 3 year average ROIC (13.15%) for CRC is well above the current ROIC(8.55%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.47%
ROE 12.09%
ROIC 8.55%
ROA(3y)14.41%
ROA(5y)20.81%
ROE(3y)29.93%
ROE(5y)N/A
ROIC(3y)13.15%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 11.34%, CRC is in line with its industry, outperforming 47.14% of the companies in the same industry.
CRC's Profit Margin has improved in the last couple of years.
The Operating Margin of CRC (17.62%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CRC has grown nicely.
CRC has a better Gross Margin (66.65%) than 70.95% of its industry peers.
CRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.62%
PM (TTM) 11.34%
GM 66.65%
OM growth 3YN/A
OM growth 5Y2.07%
PM growth 3Y-44.95%
PM growth 5Y13.96%
GM growth 3Y5.65%
GM growth 5Y0.12%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRC is creating some value.
Compared to 1 year ago, CRC has less shares outstanding
CRC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRC has been reduced compared to a year ago.

2.2 Solvency

CRC has an Altman-Z score of 2.96. This is not the best score and indicates that CRC is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.96, CRC is doing good in the industry, outperforming 73.33% of the companies in the same industry.
The Debt to FCF ratio of CRC is 2.27, which is a good value as it means it would take CRC, 2.27 years of fcf income to pay off all of its debts.
CRC has a better Debt to FCF ratio (2.27) than 74.29% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that CRC is not too dependend on debt financing.
CRC has a Debt to Equity ratio of 0.26. This is in the better half of the industry: CRC outperforms 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 2.27
Altman-Z 2.96
ROIC/WACC1
WACC8.55%

2.3 Liquidity

A Current Ratio of 1.41 indicates that CRC should not have too much problems paying its short term obligations.
With a Current ratio value of 1.41, CRC perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that CRC should not have too much problems paying its short term obligations.
The Quick ratio of CRC (1.29) is better than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.29

3

3. Growth

3.1 Past

CRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.92%.
Measured over the past years, CRC shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.95% on average per year.
Looking at the last year, CRC shows a very negative growth in Revenue. The Revenue has decreased by -37.65% in the last year.
Measured over the past years, CRC shows a decrease in Revenue. The Revenue has been decreasing by -1.78% on average per year.
EPS 1Y (TTM)-49.92%
EPS 3Y-41.55%
EPS 5Y32.95%
EPS Q2Q%-71.48%
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y21.57%
Revenue growth 5Y-1.78%
Sales Q2Q%-37.81%

3.2 Future

The Earnings Per Share is expected to grow by 8.09% on average over the next years. This is quite good.
CRC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.33% yearly.
EPS Next Y1.91%
EPS Next 2Y15.33%
EPS Next 3Y8.09%
EPS Next 5YN/A
Revenue Next Year16.03%
Revenue Next 2Y19.53%
Revenue Next 3Y4.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.83, which indicates a correct valuation of CRC.
CRC's Price/Earnings ratio is a bit more expensive when compared to the industry. CRC is more expensive than 60.95% of the companies in the same industry.
CRC is valuated rather cheaply when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.52, the valuation of CRC can be described as very cheap.
Based on the Price/Forward Earnings ratio, CRC is valued a bit cheaper than 74.29% of the companies in the same industry.
CRC is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.83
Fwd PE 7.52

4.2 Price Multiples

CRC's Enterprise Value to EBITDA ratio is in line with the industry average.
CRC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.24
EV/EBITDA 7.59

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CRC may justify a higher PE ratio.
PEG (NY)8.27
PEG (5Y)0.48
EPS Next 2Y15.33%
EPS Next 3Y8.09%

3

5. Dividend

5.1 Amount

CRC has a Yearly Dividend Yield of 2.37%. Purely for dividend investing, there may be better candidates out there.
CRC's Dividend Yield is comparable with the industry average which is at 5.93.
CRC's Dividend Yield is comparable with the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 2.37%

5.2 History

CRC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

32.41% of the earnings are spent on dividend by CRC. This is a low number and sustainable payout ratio.
DP32.41%
EPS Next 2Y15.33%
EPS Next 3Y8.09%

CALIFORNIA RESOURCES CORP

NYSE:CRC (7/26/2024, 7:23:27 PM)

After market: 51.12 0 (0%)

51.12

+0.74 (+1.47%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.58B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.37%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.83
Fwd PE 7.52
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)8.27
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 6.47%
ROE 12.09%
ROCE
ROIC
ROICexc
ROICexgc
OM 17.62%
PM (TTM) 11.34%
GM 66.65%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.41
Quick Ratio 1.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-49.92%
EPS 3Y-41.55%
EPS 5Y
EPS Q2Q%
EPS Next Y1.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y21.57%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y